Wall Street’s ever-shifting outlook on the reduction of the Federal Reserve’s balance sheet is once again in flux, with a number of banks and researchers now seeing a good chance the central bank may ...

Veritone's challenges post-divestiture, include shaky software growth, federal deal risks, and a strained balance sheet. Read ...

The Federal Reserve continued its easing cycle in Q4, yet higher-than-expected inflation in December led the Fed to signal a ...

According to the CBSE exam date sheet, the class 12 Economics 2025, paper is scheduled for March 19, 2025. The paper will ...

As stated in early February 2025, the currently anticipated level of annual revenue for 2025 is satisfactory. While revenue ...

Notice to the Annual General Meeting of NANOFORM FINLAND Plc. The shareholders of Nanoform Finland Plc (the "Company") (business ID: 2730572-8) are hereby invited to the Annual Ge ...

Rising Xenophobic Harassment and Violence towards Central Asian Migrants in Russia,” documents that Central Asian migrants, ...

Company to host conference call and webcast today at 8:30 a.m. EDT CARMIEL, Israel, March 17, 2025 /PRNewswire/ -- Protalix BioTherapeutics, Inc. (NYSE American: ...

The shareholders of SSAB AB (publ) (company reg. no. 556016-3429) are hereby given notice to the Annual General Meeting to be held on Tuesday, April 29, 2025 at 1 p.m. The Board of Directors has ...

On 3 April 2024, the Company announced publication of the results of the RED DESERT and SAHARA proof-of-concept studies, in the prestigious peer-reviewed journal European Journal of Heart Failure.